Klaudia Woszczek
Colombia
Excelente subida para nuestro portafolio Translate
Klaudia Woszczek
๐™‹๐™–๐™ง๐™š๐™ฃ๐™ฉ๐™จ, ๐™‡๐™ž๐™จ๐™ฉ๐™š๐™ฃ ๐™๐™ฅ! ๐Ÿ“ข ๐™„๐™ก๐™ก๐™ช๐™ข๐™ž๐™ฃ๐™–'๐™จ (๐™„๐™‡๐™ˆ๐™‰) ๐™Œ๐Ÿฏ ๐˜ฝ๐™š๐™–๐™ฉ ๐™„๐™จ ๐™– ๐™’๐™„๐™‰ ๐™›๐™ค๐™ง ๐™‡๐™ค๐™ฃ๐™œ-๐™๐™š๐™ง๐™ข ๐™๐™–๐™ข๐™ž๐™ก๐™ฎ ๐™ƒ๐™š๐™–๐™ก๐™ฉ๐™ ๐Ÿ’– (๐“๐ก๐ข๐ฌ ๐ข๐ฌ ๐ง๐จ๐ญ ๐ข๐ง๐ฏ๐ž๐ฌ๐ญ๐ฆ๐ž๐ง๐ญ ๐š๐๐ฏ๐ข๐œ๐ž; ๐š๐ฅ๐ฐ๐š๐ฒ๐ฌ ๐๐จ ๐ฒ๐จ๐ฎ๐ซ ๐ซ๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก! ๐๐ฎ๐ญ ๐ข๐Ÿ ๐ฒ๐จ๐ฎ ๐ฌ๐ก๐š๐ซ๐ž ๐ญ๐ก๐ข๐ฌ ๐ฏ๐ข๐ฌ๐ข๐จ๐ง, ๐ฃ๐จ๐ข๐ง ๐ญ๐ก๐ž ๐ฆ๐จ๐ฏ๐ž๐ฆ๐ž๐ง๐ญ! ๐Ÿ‘‡ ๐‚๐จ๐ฉ๐ฒ ๐Š๐ฅ๐š๐ฎ๐๐ข๐š๐Š๐–) I'm all about investing in things that matterโ€”things that will shape the world my little one grows up in. That's why I'm so bullish on Illumina ($ILMN (Illumina)), and their Q3 2025 report today just confirmed my conviction! They smashed expectations and raised their full-year forecast! ๐Ÿš€ ๐๐Ÿ‘ ๐๐ž๐š๐ญ & ๐…๐ฎ๐ญ๐ฎ๐ซ๐ž ๐๐จ๐จ๐ฌ๐ญ: ๐“๐ก๐ž ๐‡๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ! Non-GAAP EPS: A massive 1.34 usd They totally beat the high-end of their guidance. Hello, strong financials! ๐Ÿค‘ ๐๐š๐œ๐ค ๐ญ๐จ ๐†๐ซ๐จ๐ฐ๐ญ๐ก: ๐“๐ก๐ž ๐‚๐„๐Ž, ๐‰๐š๐œ๐จ๐› ๐“๐ก๐š๐ฒ๐ฌ๐ž๐ง, confirmed they've returned to growth outside of China, driven by their most important area: clinical applications. This is HUGE. It means the technology is moving from labs to real patient care. ๐“๐ก๐ž ๐‚๐ซ๐ฒ๐ฌ๐ญ๐š๐ฅ ๐๐š๐ฅ๐ฅ ๐ข๐ฌ ๐‚๐ฅ๐ž๐š๐ซ๐ž๐ซ: They raised their full-year guidance for both revenue and Non-GAAP EPS. When a company is this confident, you pay attention! They're tightening their expected revenue decline and boosting their profit outlook. Transparency and momentumโ€”love to see it! ๐Ÿ“ˆ ๐•Ž๐•™๐•ช ๐•€ ๐•€๐•Ÿ๐•ง๐•–๐•ค๐•ฅ โ„๐•–๐•ฃ๐•– ๐•’๐•ค ๐•’ ๐•„๐• ๐•ž ๐Ÿ’– Investing in genomic sequencing isn't just about money; it's about investing in the future health of the planet and my family. ๐„๐š๐ซ๐ฅ๐ฒ ๐ƒ๐ž๐ญ๐ž๐œ๐ญ๐ข๐จ๐ง: Illuminaโ€™s tech makes it possible to detect diseases earlier than everโ€”think non-invasive prenatal testing (NIPT) and cancer screenings. Investing here is investing in more safe days for all our kids. ๐๐ž๐ซ๐ฌ๐จ๐ง๐š๐ฅ๐ข๐ณ๐ž๐ ๐Œ๐ž๐๐ข๐œ๐ข๐ง๐ž: Sequencing unlocks truly personalized healthcare. My child's future doctor might use their unique genome to prescribe the perfect medicine, minimizing side effects and maximizing results. That's a healthcare revolution! ๐Ÿ’Š ๐ˆ๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง ๐๐จ๐ฐ๐ž๐ซ๐ก๐จ๐ฎ๐ฌ๐ž: They pumped out 228 million USD in R&D this quarter! They're not sitting still; they're innovating the tools that power almost all genetic research globally. This creates a moat around their business that is almost impossible to cross. This is one of those foundational companies that is literally building the future. The Q3 numbers show they're executing their strategy and moving forward. Don't just watch the future happen; invest in it! ๐“๐ก๐ข๐ฌ ๐ข๐ฌ ๐ง๐จ๐ญ ๐ข๐ง๐ฏ๐ž๐ฌ๐ญ๐ฆ๐ž๐ง๐ญ ๐š๐๐ฏ๐ข๐œ๐ž; ๐š๐ฅ๐ฐ๐š๐ฒ๐ฌ ๐๐จ ๐ฒ๐จ๐ฎ๐ซ ๐ซ๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก! ๐๐ฎ๐ญ ๐ข๐Ÿ ๐ฒ๐จ๐ฎ ๐ฌ๐ž๐ž ๐ญ๐ก๐ž ๐ฏ๐ข๐ฌ๐ข๐จ๐ง, ๐ฃ๐จ๐ข๐ง ๐ญ๐ก๐ž ๐ฆ๐จ๐ฏ๐ž๐ฆ๐ž๐ง๐ญ! ๐Ÿ‘‡ ๐‚๐จ๐ฉ๐ฒ ๐Š๐ฅ๐š๐ฎ๐๐ข๐š๐Š๐–!
null
.